Black Hawk Acquisition Corp Secures $300K Convertible Note from Sponsor at Deep Discount for DeSPAC

summarizeSummary

Black Hawk Acquisition Corp secured a convertible promissory note for up to $300,000 from its sponsor to fund working capital for its pending DeSPAC transaction, with a conversion price of $1.00 per share.

check_boxKey Events · Financing and Capital Events · BKHA

• Secures Convertible Note

  Black Hawk Acquisition Corp issued a convertible promissory note for up to $300,000 to its sponsor, Black Hawk Management LLC, on May 4, 2026.

• Working Capital for DeSPAC

  The funds are designated for working capital expenses related to the company's ongoing DeSPAC transaction with Vesicor Therapeutics, Inc.

• Highly Dilutive Conversion Terms

  The note bears 10% interest and is convertible into shares of the post-merger company at a price of $1.00 per share, a significant discount to the current market price of $11.86.

• Sponsor Commitment

  The financing from the sponsor indicates their continued commitment to the completion of the business combination, providing crucial capital for the process.

auto_awesomeAnalysis · BKHA · Life Sciences

This 8-K filing details a critical financing step for Black Hawk Acquisition Corp as it progresses towards its merger with Vesicor Therapeutics, a transaction previously highlighted in an S-4/A filing on May 1, 2026. While the $300,000 convertible note from the sponsor provides necessary working capital to complete the DeSPAC, the conversion terms are highly dilutive for existing shareholders. The sponsor has the option to convert the principal into shares of the post-merger company at a price of $1.00 per share, a substantial discount to the current market price of $11.86. This arrangement highlights the company's need for capital to finalize the merger, but at a significant potential cost in terms of future share dilution. Investors should monitor the closing of the DeSPAC and any subsequent conversion by the sponsor.